Exploring the Efficacy of Ketoconazole versus Ketoconazole Combined with Adapalene in Treating Pityriasis Versicolor: A Comparative Study: Ketoconazole versus Ketoconazole Adapalene in Pityriasis

Shafiq Ahmad; Shabir Hussain; Amjad Mustafa; Sumera Feroz; Shafaq Zafar; Ghazala Shaheen

doi:10.54393/pjhs.v5i08.1679

Authors

Shafiq Ahmad Department of Pharmacology, Khyber Medical University Institute of Medical/Dental Science, Kohat, Pakistan
Shabir Hussain Department of Pharmacology, Bannu Medical College, Bannu, Pakistan
Amjad Mustafa Department of Pharmacology, Khyber Medical University Institute of Medical/Dental Science, Kohat, Pakistan
Sumera Feroz Department of Pharmacology, Khyber Medical University Institute of Medical/Dental Science, Kohat, Pakistan
Shafaq Zafar Department of Pharmacology, Peshawar Medical College, Peshawar, Pakistan
Ghazala Shaheen Department of Pharmacology, Khyber Medical University Institute of Medical/Dental Science, Kohat, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i08.1679

Keywords:

Adapalene, Antifungal Treatment, Ketoconazole, Pityriasis Versicolor

Abstract

Pityriasis versicolor, a fungal infection causing skin discoloration, was commonly treated with antifungal agents like ketoconazole and adapalene, either alone or in combination. Objective: To compare the efficacy of ketoconazole alone versus the combination of ketoconazole and adapalene in the treatment of pityriasis versicolor. Methods: This study was conducted at Department of Pharmacology, Banu Medical College, Banu from May 2023 to October 2023. Total 90 (45 in each group) adult patients diagnosed with the condition were assigned to either treatment group. Group A was treated with ketoconazole 2% cream monotherapy, while Group-B was given combined therapy with ketoconazole 2% cream and adapalene 1% gel. Both groups underwent treatment for duration of four weeks, with instructions for application provided by the investigators. Treatment outcomes, including lesion clearance rates were evaluated at follow-up. The collected data underwent processing and analysis utilizing IBM SPSS, version 23.0. Results: Out of total participants 57 (63.3%) were male and 33 (36.7%) were females, with a mean age of 30.63 ± 8.38 years. Regarding lesion type, the distribution between hyperpigmented (51.1%) and hypopigmented (48.9%) lesions were relatively balanced. This study depicted a significantly higher proportion of patients in the combination therapy group (n=39, 86.7%) experienced improvement compared to those in the ketoconazole monotherapy group 21 (46.7%) (p < 0.001). Conclusions: In conclusion, this study demonstrates that the combination of ketoconazole and adapalene exhibits superior efficacy compared to ketoconazole alone in treating pityriasis versicolor.

References

Wang L and Xing H. Pityriasis versicolor on the scalp: An unusual distribution of a common disease. Pediatric Investigation. 2023 Sep; 7(03): 216-7. doi: 10.1002/ped4.12387. DOI: https://doi.org/10.1002/ped4.12387

Wirawan IG and Wijaya IM. Prevalence and Characteristic of Superficial Fungal Infection in Denpasar City, Bali, Indonesia. International Journal of Bioscience and Biotechnology. 2023; 11(1): 1-7. doi: 10.5678/ijbb.2023.11.1.1-7.

Chebil W, Haouas N, Chaâbane-Banaoues R, Remadi L, Chargui N, M'rad S et al. Epidemiology of pityriasis versicolor in Tunisia: clinical features and characterization of Malassezia species. Journal of Medical Mycology. 2022 May; 32(2): 101246. doi: 10.1016/j.mycmed.2022.101246. DOI: https://doi.org/10.1016/j.mycmed.2022.101246

Ismail BA, Fatima SH, Nawab M. The current understanding of the clinical condition Bahaq (Pityriasis Versicolor)-hypothesis and a review of evidences. Traditional and Integrative Medicine. 2021 Sep: 249-58. doi: 10.18502/tim.v6i3.7313. DOI: https://doi.org/10.18502/tim.v6i3.7313

Lunjani N, Ahearn-Ford S, Dube FS, Hlela C, O'Mahony L. Mechanisms of microbe-immune system dialogue within the skin. Genes & Immunity. 2021 Oct; 22(5): 276-88. doi: 10.1038/s41435-021-00133-9. DOI: https://doi.org/10.1038/s41435-021-00133-9

Vishwanath T, Kapadia FM, Mahajan SA, Kharkar VD, Chikhalkar SB, Gole PV et al. Dermoscopic Perspective of Pityriasis Versicolor in a Cross-Sectional Study. Indian Dermatology Online Journal. 2024 Mar; 15(2): 218-25. doi: 10.4103/idoj.idoj_319_23. DOI: https://doi.org/10.4103/idoj.idoj_319_23

Łabędź N, Navarrete-Dechent C, Kubisiak-Rzepczyk H, Bowszyc-Dmochowska M, Pogorzelska-Antkowiak A, Pietkiewicz P. Pityriasis versicolor-a narrative review on the diagnosis and management. Life. 2023 Oct; 13(10): 2097. doi: 10.3390/life13102097. DOI: https://doi.org/10.3390/life13102097

Mumdzhiev NH, Radicheva DV, Radicheva MP, Tenev RV, Vasileva ZD. Spontaneous Clearance of Chronic HCV: The Key Ending Left in the Dark. Open Access Macedonian Journal of Medical Sciences. 2019 May; 7(10): 1657. doi: 10.3889/oamjms.2019.134. DOI: https://doi.org/10.3889/oamjms.2019.134

Mahmoud Y, Metwally M, Mubarak H, Zewawy N. Treatment of tinea versicolor caused by Malassezia furfur with dill seed extract: an experimental study. International Journal of Pharmacy and Pharmaceutical Sciences. 2015; 7(2): 1-7.

Hassan S and Ranjan A. Therapeutic efficacy of topical luliconazole versus topical ketoconazole in the treatment of pityriasis versicolor patients: A hospital based comparative study. International Journal of Research in Dermatology. 2020 Mar; 6: 248-52. doi: 10.18203/issn.2455-4529. DOI: https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20200606

Ashraf S. Comparison of topical ketoconzole alone versus topical ketoconazole plus topical adapalene in the treatment of patients with pityriasis versicolor. MedERA-Journal of CMH LMC and IOD. 2018;2. doi: 10.61982/medera.v2i.22.

Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane database of Systematic Reviews. 2008. doi: 10.1002/14651858.CD003437.pub3. DOI: https://doi.org/10.1002/14651858.CD003437.pub3

Shah S, Kemp JM, Kvedar JC, Gracey LE. A feasibility study of the burden of disease of atopic dermatitis using a smartphone research application, myEczema. International Journal of Women's Dermatology. 2020 Dec; 6(5): 424-8. doi: 10.1016/j.ijwd.2020.08.001. DOI: https://doi.org/10.1016/j.ijwd.2020.08.001

Jha S. Efficacy of Azoles Antifungals in Treatment of Pityriasis Versicolor. Journal of Nepalgunj Medical College. 2021 Jan; 19(1): 43-6. doi: 10.3126/jngmc.v19i1.40226. DOI: https://doi.org/10.3126/jngmc.v19i1.40226

Mohankar A. Study of ketoconazole 2% in a shampoo base clears pityriasis versicolor. Global Journal for Research Analysis. 2017 Aug; 11(6): 2277-8160. doi: 10.18535/gjra/v11i6.12.

Hameed S, Paracha MM, Sagheer F, Khan AQ, Noor SM. Comparative study of efficacy of combined treatment with ketoconazole 2% cream and adapalene 0.1% gel vs. Ketoconazole 2% cream monotherapy in pityriasis versicolor. American Journal of Health, Medicine and Nursing Practice. 2022 May; 7(6): 33-40. doi: 10.47672/ajhmn.1029. DOI: https://doi.org/10.47672/ajhmn.1029

Tawfik KM, Mahmmoud WA, Ali AG. Ketoconazole 2% cream versus a combination of ketoconazole 2% cream and adapalene 0.1% gel in the treatment of pityriasis versicolor. Al-Azhar Assiut Medical Journal. 2022 Jan; 20(1): 100-3. doi: 10.4103/azmj.azmj_97_21. DOI: https://doi.org/10.4103/azmj.azmj_97_21

Shi TW, Zhang JA, Tang YB, Yu HX, Li ZG, Yu JB. A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor. Journal of Dermatological Treatment. 2015 Mar; 26(2): 143-6. doi: 10.3109/09546634.2014.921661. DOI: https://doi.org/10.3109/09546634.2014.921661

Sirri L, Grandi S, Tossani E. Medically unexplained symptoms and general practitioners: a comprehensive survey about their attitudes, experiences and management strategies. Family Practice. 2017 Apr; 34(2): 201-5. doi: 10.1093/fampra/cmw130. DOI: https://doi.org/10.1093/fampra/cmw130

Gobbato AA, Babadópulos T, Gobbato CA, Ilha JD, Gagliano-Jucá T, De Nucci G. A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor. Expert Opinion on Investigational Drugs. 2015 Nov; 24(11): 1399-407. doi: 10.1517/13543784.2015.1083009. DOI: https://doi.org/10.1517/13543784.2015.1083009

Bakr E, Abdo H, Abd‐Elaziz H, Abd‐Elrazek H, Amer M. Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study. Dermatologic Therapy. 2020 May; 33(3): e13319. doi: 10.1111/dth.13319. DOI: https://doi.org/10.1111/dth.13319

Dyer JM and Foy VM. Revealing the unseen: a review of Wood's lamp in dermatology. The Journal of Clinical and Aesthetic Dermatology. 2022 Jun; 15(6): 25.